Cesar Munoz-Fontela

Cesar Munoz-Fontela

Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology

Affiliated withHeinrich Pette Institute, Leibniz Institute for Experimental Virology

Research Area

Biography

Cesar Munoz-Fontela has not added Biography.
If you are Cesar Munoz-Fontela and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Publication title

Cited by 1

2015

Other Publications

Article
Year
Direct visualization of the microtubular cytoskeleton of ciliated protozoa with a fluorescent taxoid.

The Journal of eukaryotic microbiology| PubMed ID: 12188221

2002
2003
Antiviral action of the tumor suppressor ARF.

The EMBO journal| PubMed ID: 16957780

2006
2007
Control of virus infection by tumour suppressors.

Carcinogenesis| PubMed ID: 17347139

2007
2005
Transcriptional role of p53 in interferon-mediated antiviral immunity.

The Journal of experimental medicine| PubMed ID: 18663127

2008
2009
2010
Acetylation is indispensable for p53 antiviral activity.

Cell cycle (Georgetown, Tex.)| PubMed ID: 22033337

2011
2011
2012
2012
SUMOylation of p53 mediates interferon activities.

Cell cycle (Georgetown, Tex.)| PubMed ID: 23966171

2013
2014
2014
Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology| PubMed ID: 25600600

2015
KSHV latent protein LANA2 inhibits sumo2 modification of p53.

Cell cycle (Georgetown, Tex.)| PubMed ID: 25607652

2015
2015
2015
2015